Clinical trial
The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
NCT01663662
Study timeline
Study start (unknown)2012-08-01Date precision: month
Registry last updated2015-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
TolvaptanDRUG · verified · RxNorm: tolvaptan
placeboDRUG
Sponsors & collaborators
University of Michiganlead sponsor
Otsuka Pharmaceuticalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01663662 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.